a. < 10 years (n = 18,022) | |
---|---|
Seizure, n (%) | 390 (2.2) |
Anaphylactic reaction, n (%) | 374 (2.1) |
Abnormal behavior, n (%) | 374 (2.1) |
Hepatic function abnormal, n (%) | 336 (1.9) |
Pyrexia, n (%) | 319 (1.8) |
Anaphylactic shock, n (%) | 271 (1.5) |
Stevens-Johnson syndrome, n (%) | 246 (1.4) |
Rash, n (%) | 229 (1.3) |
Erythema multiforme, n (%) | 195 (1.1) |
Drug eruption, n (%) | 156 (0.9) |
b. 10–19 years (n = 15,157) | |
Abnormal behavior, n (%) | 419 (2.8) |
Anaphylactic shock, n (%) | 353 (2.3) |
Anaphylactic reaction, n (%) | 333 (2.2) |
Pyrexia, n (%) | 236 (1.6) |
Seizure, n (%) | 223 (1.5) |
Hepatic function abnormal, n (%) | 220 (1.5) |
Stevens-Johnson syndrome, n (%) | 175 (1.2) |
Drug reaction with eosinophilia and systemic symptoms, n (%) | 171 (1.1) |
Pancreatitis acute, n (%) | 170 (1.1) |
Rash, n (%) | 169 (1.1) |